Patents
Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726)
08/2004
08/31/2004US6784187 8-carboxamido-2,6-methano-3-benzazocines
08/31/2004US6784173 Aromatic dicarboxylic acid derivatives
08/31/2004US6783948 Chemiluminescent acridinium compounds and analogues thereof as substrates of hydrolytic enzymes
08/26/2004WO2004072206A1 Organic electroluminescent device
08/26/2004WO2004072074A1 Pyrrolidinohydrochinazolines
08/26/2004WO2004072031A2 Phenylacetamides and their use as glucokinase modulators
08/26/2004WO2004071382A2 Substituted heterocycles
08/26/2004WO2004045562A3 Mixed kappa/mu opioids and uses thereof
08/26/2004WO2004017922B1 Keto cannabinoids with therapeutic indications
08/26/2004US20040167157 reacting a pyridinyl ketone with a halogenating agent in acetonitrile and dimethylformamide; hydrolysis, animation to get a 3-amino 4-halo pyridine; chemical intermediate; by-product inhibition
08/26/2004US20040167145 moderator of cholinergic agent; mixture of acetylcholinesterase inhibitors and opioiod receptor blockers
08/26/2004US20040167141 Anticancer agents; antidiabetic agents; Alzheimer's disease
08/26/2004US20040167115 induction apoptosis; Dna replication inhibition; p38 MAP kinase activation or caspase cascading activation, or cytochromic C release from mitochondria into cytoplasm
08/26/2004US20040167031 Arylphenyl-substituted cyclic ketoenols
08/26/2004CA2515670A1 Phenylacetamides and their use as glucokinase modulators
08/25/2004EP1449835A2 Alpha-substituted pyrimidine-thioalkyl and alkylether compounds
08/25/2004EP1448566A2 Chemokine receptor antagonists and methods of use thereof
08/25/2004EP1448544A1 Substituted benzopyrans as selective estrogen receptor-beta agonists
08/25/2004CN1523025A Method for producing pyridine derivatives
08/25/2004CN1163495C Pyridine compounds, preparation method thereof and pharmaceutical compositions containing them
08/25/2004CN1163224C Drugs for improving vesical excretory capacity
08/24/2004US6781001 Extended rhodamine dye compound suitable for the creating of sets of spactrally resolvable fluorescent labels particlularly useful for fluorescence based dna sequencing system
08/24/2004US6780997 Such as dibenzyl(a,3-o-isopropylidiene-3-hydroxy-4-hydroxymethyl-2-methyl-5-pyridyl) hydroxymethylphosphonate which functions like pyridoxal-5'-phosphate in vivo; drug screening; antidiabetic agents
08/24/2004US6780875 Quinoline-4-carboxamide derivatives as NK-3 and NK-2 receptor antagonists
08/24/2004US6780872 Asthma; antiepileptic agents; sexual disorders
08/24/2004US6780868 Treatment of myocardial or peripheral ischaemia, cardiac insufficiency or pulmonary arterial hypertension
08/19/2004WO2004069840A2 Production of tetrahydroquinoline benzofurans
08/19/2004WO2004069829A1 (2s)-2-((pyrimidin-4-yl)amino)-4-methylpentanoic acid aminoethylamid derivatives as il-8 receptor modulators for the treatment of atherosclerosis and rheumatoid arthritis
08/19/2004WO2004069824A1 Pyrazole derivative
08/19/2004WO2004069813A1 Saturated quinoxaline derivatives and their use as metabotropic glutamate receptor ligands
08/19/2004WO2004069798A1 Melanin-concentrating hormone receptor antagonists containing piperidine derivatives as the active ingredient
08/19/2004WO2004069792A2 Quinoline-derived amide modulators of vanilloid vr1 receptor
08/19/2004WO2004069249A1 3-cyano-quinoline derivatives as non-receptor tyrosine kinase inhibitors
08/19/2004WO2004069245A1 Oxazolidinone derivates n-substituted by a tricyclic ring, for use as antibacterial agents
08/19/2004WO2004069197A2 Novel substituted 2,3-benzodiazepine derivatives
08/19/2004WO2004058755A3 Compound libraries of imidazo[1,5-a]pyridin-3-yl derivatives and related heterobicycles for targetting compounds capable of binding to g-protein coupled receptors
08/19/2004WO2004058720A3 Compound libraries of 1,3,5-substitute indazole derivatives as compounds for targetting compounds capable of binding to the g-protein coupled receptor
08/19/2004WO2004029579A3 Fluorescent labeling reagents with multiple donors and acceptors
08/19/2004WO2004009036A3 Compounds compositions and methods
08/19/2004US20040162410 Thrombosis therapy; anticoagulants
08/19/2004US20040162299 Substituted quinazolines and analogs and the use thereof
08/19/2004DE10304950A1 Herstellung von Tetrahydrochinolinbenzofuranen Production of Tetrahydrochinolinbenzofuranen
08/19/2004CA2515717A1 Melanin-concentrating hormone receptor antagonists containing piperidine derivatives as the active ingredient
08/19/2004CA2515119A1 Pyrazole derivative
08/19/2004CA2514940A1 Quinoline-derived amide modulators of vanilloid vr1 receptor
08/19/2004CA2514241A1 Oxazolidinone derivates n-substituted by a tricyclic ring, for use as antibacterial agents
08/19/2004CA2513824A1 Saturated quinoxaline derivatives and their use as metabotropic glutamate receptor ligands
08/19/2004CA2512616A1 Novel substituted 2,3-benzodiazepine derivatives
08/18/2004EP1446387A1 Substituted aryl 1,4-pyrazine derivatives
08/18/2004EP1311487A4 Derivatives of 1,2-dihydro-7-hydroxyquinolines containing fused rings
08/18/2004CN1522254A Immunomodulating compounds
08/18/2004CN1522249A Quinoline derivatives as ligands for the neuropeptide y receptor
08/18/2004CN1162433C Method for purifying tetrodotoxin
08/18/2004CN1162432C 2,3-benzodiazepine derivatives
08/18/2004CN1162428C Method for producing pyridine derivatives
08/18/2004CN1162061C 10-hydroxy camptothecine, and method for processing raw material of camptothecine
08/17/2004US6777555 3-(optionally hydroxyl)-4-(cyclopropylcarbonyl)-cumene intermediate
08/17/2004US6777426 Imidazole and imidazoline derivatives and uses thereof
08/17/2004US6777425 Which binds nucleic acids/dna; gene expression; genetic engineering
08/17/2004US6777410 Isoindole derivatives
08/17/2004US6777237 Bioconjugate comprises the bioactive agent and an organocobalt complex
08/17/2004US6776976 Bioactive agent is covalently conjugated to an organocobalt complex's cobalt atom through a non-reactive atom in the bioactive agent molecule such as peptide, protein, nucleic acid and analogues
08/12/2004WO2004067529A1 Indole-derivative modulators of steroid hormone nuclear receptors
08/12/2004WO2004054504A3 Tricyclic aminocyanopyridine inhibitors of mitogen activated protein kinase-activated protein kinase-2
08/12/2004WO2004052893A3 Substituted dihydropyrano indole-3,4-dione derivatives and 3-oxoacetic acid substituted 2-hydroxymethylindole derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1)
08/12/2004WO2004044174A3 Topoisomerase-targeting agents
08/12/2004WO2004043392A3 Mucin synthesis inhibitors
08/12/2004WO2003093231A3 Tetrahydropyranyl cyclopentyl tetrahydroisoquinoline modulators of chemokine receptor activity
08/12/2004WO2003092374A3 Pesticidal heterocycles
08/12/2004US20040158071 Novel benzylpiperidine compound
08/12/2004US20040158060 Multistage reaction of carbamazepine with peroxyacetic acid and metal catalyst in solvent and catalytic hydrogenation
08/12/2004US20040157897 Polymorphs of an epothilone analog
08/12/2004US20040157893 Pyrazole compounds useful as protein kinase inhibitors
08/12/2004US20040157863 Triazolopyrimidines
08/12/2004US20040157844 6-azauracil derivatives as thyroid receptor ligands
08/12/2004US20040157827 2-Ureido-thiazole derivatives, process for their preparation, and their use as antitumor agents
08/12/2004US20040156869 Also 2-substituted quinolines, isoquinolines, pyridoquinolines, pyridoisoquinolines, and pyridoquinazolines; treatment of conditions responsive to capsaicin receptor modulation, especially various kinds of pain
08/12/2004DE10304055A1 Verfahren zur Herstellung von Ketalen Process for the preparation of ketals
08/12/2004CA2511806A1 Indole-derivative modulators of steroid hormone nuclear receptors
08/11/2004EP1445257A1 Chromene compound
08/11/2004EP1444221A1 Halogenated nitrobutadienes for controlling animal pests
08/11/2004EP1443933A2 Treatment of chronic myelogenous leukemia, resistant or intolerant to sti571, involving homoharringtonine alone or combined with other agents
08/11/2004EP1109813B1 Pyrroloindoles, pyridoindoles and azepinoindoles as 5-ht2c agonists
08/11/2004EP1042294B1 Heterocyclic cytotoxic agents
08/11/2004EP0937047B1 1-arylphthalazine antagonists of excitatory amino acid receptors
08/11/2004CN1520294A Crystalline anticholinergic, method for its prodn., and use thereof in prdon of drug
08/11/2004CN1519242A Compound of benzopyran category marked by fluorin [*F] as well as preparation method and its application of developing agent for D4 receptor of dopamine
08/11/2004CN1519241A Dehydrogenation 'nudike' alkali and preparation method as well as preparation method for synthesizing 'nudike' alkali
08/11/2004CN1161336C Quinolinecarboxamides as antiviral agents
08/11/2004CN1161334C Nitrogen-containing tegracyclic compounds
08/10/2004US6774133 Substituted spiroheterocyclic 1H-3-aryl-pyrrolidine-2,4-dione derivatives, processes for their preparation, and their use as pesticides
08/10/2004US6774132 Spirooxindole derivatives that act as analgesics
08/10/2004US6774116 Prodrugs via acylation with cinnamate
08/05/2004WO2004065539A2 Androgen receptor antagonists
08/05/2004WO2004065520A1 Light-emitting device, condensed polycyclic compound used therein and method for producing same
08/05/2004WO2004065379A1 Androgen receptor antagonists
08/05/2004WO2004065366A1 2.4-dihalogen-6-(c2-c3-alkyl)-phenyl substituted tetramic acid derivatives
08/05/2004WO2004037169A3 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
08/05/2004WO2003051303A3 The total synthesis of merrilactone a
08/05/2004US20040152920 Preparation of ketals